Zevra Therapeutics (ZVRA) Inventory (2024 - 2026)

Zevra Therapeutics has reported Inventory for 3 years, with the latest figure at $2.3 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory fell 9.73% year-over-year to $2.3 million; the trailing twelve-month figure through Mar 2026 stood at $2.3 million (down 9.73% YoY), and the FY2025 full-year result was $1.7 million, down 11.68% from the prior year.
• Inventory for Q1 2026 stood at $2.3 million, up from $1.7 million in the prior quarter.
• The five-year high for Inventory was $2.6 million in Q1 2025, with the low at $1.1 million in Q2 2025.
• Historically, Inventory has averaged $1.8 million across 3 years, with a median of $1.9 million in 2024.
• Annual changes were most pronounced in 2025 — Inventory retreated 11.68% — and 2026, when it slipped 9.73%.
• Zevra Therapeutics' Inventory stood at $2.0 million in 2024, then retreated by 11.68% to $1.7 million in 2025, then surged by 32.76% to $2.3 million in 2026.
• The last three Inventory figures came in at $2.3 million (Q1 2026), $1.7 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.